2024 ISPE Europe Annual Conference

Conference Overview

This European Annual Conference draws pharmaceutical and biopharmaceutical professionals at all levels of the industry - from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment and services, and global regulatory agencies. We welcome you to participate at the 2024 ISPE Europe Annual Conference to learn and share progress, success stories, best practices and lessons learned.

Regulatory Presence at the 2024 ISPE Europe Annual Conference:


Featured Session Speakers


Conference Topics

The 2024 Europe Annual Conference Programme Committee is requesting proposals aligning with the following content areas:


Why Attend the 2023 ISPE Europe Annual Conference?

Highlighted Sessions


Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2024 ISPE Europe Annual Conference.

Name
Company Type
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

International Programme Committee

Udo J. Vetter
Head of the Advisory Board
Vetter Pharma International GmbH
Executive Chair
Cristina Mazó
Site Manager
GP Pharm
Conference Chair
Teresa Minero
Founder & CEO
LifeBee - Digitalizing Life Sciences
International Board Liaison/Foundation Board Liaison
Thomas Carganico
Vice President Strategic Development, Marketing & Communication - Partner
PQE Group
Women in Pharma® Liaison
Michael A.M. ATZOR, PhD
Senior Consultant&Expert Pharmaceutical Eng&PM
ISPE D/A/CH
Mark Birse
Vice President Technical
Parexel
David Churchward
Head of Operations Quality, Compliance and External Affairs
AstraZeneca
Richard Denk
Senior Consultant Aseptic Processing & Containment
SKAN AG
Yvonne Duckworth, PE
Fellow - Digital Technology, Associate
CRB
Jean Francois Duliere
Reg Advisor
ISPE
David Estapé, PhD
Technology Manager Biotechnology
CRB Group GmbH
Frank Henrichmann
Sr. Exec. Consultant
QFINITY
Oliver Herrmann
Managing Director
Q-FINITY Quality Management
Alice Redmond, PhD
Chief Strategy Officer
CAI
Søren Thuesen Pedersen
Senior Director, External Affairs, Quality Intelligence & Inspection
Novo Nordisk
Heather D. Watson
Director
TenTenTen Consulting Ltd
Christian Wölbeling
Executive Industry Advisor
Körber Pharma Software GmbH
Emerging Leader
Placeholder Person Graphic
Michael Hell, PhD
Head of Environment & Sustainability Healthcare Operations
Merck KGaA
Emerging Leader
Laura Kuger
PhD Candidate
Karlsruhe Institute of Technology (KIT)
Emerging Leader
Violeta Mihailova
Sr. Specialist QA Operations
Bristol Myers Squibb
Emerging Leader

Conference Sponsors

Roche

Tulip